GMP API Audit Reports

Due to the COVID-19 expansion geographically, most GMP inspections have been suspended, traveling limited and a lot of companies begin teleworking.

To maintain business continuity, Inpharmatis provides comprehensive and detailed GMP audit reports of active pharmaceutical ingredients (API) manufacturers performed by our highly experienced, qualified and certified auditors.

By purchasing our GMP API audit reports your organization:

    • reduce the COVID-19 impact on business
    • save time and money
    • diminish the workload of specialists in the workplace
    • receive detailed reports accepted by regulatory authorities worldwide

We guarantee:

  • that all audits are performed by certified auditors
  • independence and quality of audits
  • confidentiality
  • speed of information provision

The current list of APIs audited by Inpharmatis available below. To purchase API Audit reports and for additional information, please contact us: audits@inpharmatis.com.

 

Related Products                 

 

Country

Actual Audit Date (dd/mm/yyyy)
Abacavir sulfate API audit report   India 03.09.2019
Abacavir sulfate API audit report   India 10.09.2019
Abacavir sulfate API audit report   India 06.09.2019
Amoxicillin Sodium and Clavulanate Potassium 5:1 API audit report   China 09.12.2019
Atazanavir Sulfate API audit report   India 10.09.2019
Benzydamine HCl API audit report   India 04.12.2019
Chondrotin sulfate API audit report Spain 26.11.2019
Cycloserine API audit report   Korea 21.10.2019
Cycloserine API audit report   India 18.12.2019
Darunavir Amorphous API audit report   India 06.09.2019
Darunavir Amorphous API audit report   India 10.09.2019
Darunavir API audit report   India 03.09.2019
Diclofenac Sodium audit report
   India 12.03.2020
       
Efavirenz API audit report   India 03.09.2019
Efavirenz API audit report   India 10.09.2019
Emtricitabine API audit report   India 10.09.2019
Fludarabine Phosphate API audit report   China 04.12.2019
Gliclazide API audit report   China 02.12.2019
Imipenem and Cilastatin sodium with Sodium Bicarbonate API audit report   China 09.12.2019
Ketoprofen API audit report   China 02.12.2019
Lamivudine API audit report   India 06.09.2019
Lamivudine API audit report   India 10.09.2019
Levetiracetam (Form-I) API audit report   India 10.09.2019
Lidocaine HCl API audit report   India 16.12.2019
Linezolid API audit report   India 04.09.2019
Magnesium chloride API audit report   India 20.12.2019
Magnesium chloride API audit report   India 20.12.2019
Magnesium chloride hexahydrate API audit report   India 20.12.2019
Magnesium oxide API audit report   India 20.12.2019
Malic acid API audit report   India 20.12.2019
Nevirapine Anhydrous API audit report   India 06.09.2019
Nevirapine Anhydrous API audit report   India 10.09.2019
Ondansetron HCl API audit report   China 16.12.2019
Phenazone API audit report   China 18.12.2019
Potassium hydroxide API audit report   India 20.12.2019
Pyrazinamide API audit report   India 23.11.2019
Rilpivirine HCl API audit report   India 03.09.2019
Ritonavir API audit report   India 10.09.2019
Saquinavir Mesylate API audit report   India 03.09.2019
Saquinavir Mesylate API audit report   India 06.09.2019
Sitagliptin HCl monohydrate API audit report   China 02.12.2019
Sodium acetate trihydrate API audit report   India 20.12.2019
Sodium gluconate API audit report   India 20.12.2019
Sodium Hyaluronate API audit report   China 20.12.2019
Tenofovir API audit report   India 06.09.2019
Tenofovir Disoproxil Fumarate API audit report   India 10.09.2019
Terizidone API audit report   Korea 21.10.2019
Voriconazole API audit report   India 05.09.2019
Zidovudine API audit report   India 06.09.2019
Zidovudine API audit report   India 10.09.2019
       

To purchase API Audit reports and for additional information, please contact us: 

E-mail: audits@inpharmatis.com
Phone: +371 6000 3500